Switch to:
Also traded in: Germany

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 9/10

vs
industry
vs
history
Cash-to-Debt No Debt
ALGN's Cash-to-Debt is ranked higher than
99% of the 332 Companies
in the Global Medical Devices industry.

( Industry Median: 2.36 vs. ALGN: No Debt )
Ranked among companies with meaningful Cash-to-Debt only.
ALGN' s Cash-to-Debt Range Over the Past 10 Years
Min: 5.57  Med: No Debt Max: No Debt
Current: No Debt
5.57
No Debt
Equity-to-Asset 0.65
ALGN's Equity-to-Asset is ranked higher than
54% of the 312 Companies
in the Global Medical Devices industry.

( Industry Median: 0.63 vs. ALGN: 0.65 )
Ranked among companies with meaningful Equity-to-Asset only.
ALGN' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.55  Med: 0.75 Max: 0.89
Current: 0.65
0.55
0.89
Interest Coverage No Debt
ALGN's Interest Coverage is ranked higher than
99% of the 212 Companies
in the Global Medical Devices industry.

( Industry Median: 68.39 vs. ALGN: No Debt )
Ranked among companies with meaningful Interest Coverage only.
ALGN' s Interest Coverage Range Over the Past 10 Years
Min: 98.99  Med: No Debt Max: No Debt
Current: No Debt
98.99
No Debt
Piotroski F-Score: 7
Altman Z-Score: 26.33
Beneish M-Score: -2.52
WACC vs ROIC
13.02%
50.14%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 8/10

vs
industry
vs
history
Operating Margin % 24.00
ALGN's Operating Margin % is ranked higher than
91% of the 316 Companies
in the Global Medical Devices industry.

( Industry Median: 1.96 vs. ALGN: 24.00 )
Ranked among companies with meaningful Operating Margin % only.
ALGN' s Operating Margin % Range Over the Past 10 Years
Min: -10.89  Med: 17.06 Max: 26.54
Current: 24
-10.89
26.54
Net Margin % 15.71
ALGN's Net Margin % is ranked higher than
85% of the 316 Companies
in the Global Medical Devices industry.

( Industry Median: 1.42 vs. ALGN: 15.71 )
Ranked among companies with meaningful Net Margin % only.
ALGN' s Net Margin % Range Over the Past 10 Years
Min: -10.01  Med: 15.47 Max: 26.31
Current: 15.71
-10.01
26.31
ROE % 21.23
ALGN's ROE % is ranked higher than
91% of the 303 Companies
in the Global Medical Devices industry.

( Industry Median: 1.48 vs. ALGN: 21.23 )
Ranked among companies with meaningful ROE % only.
ALGN' s ROE % Range Over the Past 10 Years
Min: -12.72  Med: 19.29 Max: 42.13
Current: 21.23
-12.72
42.13
ROA % 14.68
ALGN's ROA % is ranked higher than
92% of the 333 Companies
in the Global Medical Devices industry.

( Industry Median: -0.20 vs. ALGN: 14.68 )
Ranked among companies with meaningful ROA % only.
ALGN' s ROA % Range Over the Past 10 Years
Min: -9.86  Med: 14.14 Max: 31.86
Current: 14.68
-9.86
31.86
ROC (Joel Greenblatt) % 134.54
ALGN's ROC (Joel Greenblatt) % is ranked higher than
96% of the 328 Companies
in the Global Medical Devices industry.

( Industry Median: 3.76 vs. ALGN: 134.54 )
Ranked among companies with meaningful ROC (Joel Greenblatt) % only.
ALGN' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: -114.37  Med: 151.29 Max: 369.18
Current: 134.54
-114.37
369.18
3-Year Revenue Growth Rate 18.40
ALGN's 3-Year Revenue Growth Rate is ranked higher than
83% of the 256 Companies
in the Global Medical Devices industry.

( Industry Median: 4.00 vs. ALGN: 18.40 )
Ranked among companies with meaningful 3-Year Revenue Growth Rate only.
ALGN' s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: 7.6  Med: 15.4 Max: 146.7
Current: 18.4
7.6
146.7
3-Year EBITDA Growth Rate 35.60
ALGN's 3-Year EBITDA Growth Rate is ranked higher than
83% of the 235 Companies
in the Global Medical Devices industry.

( Industry Median: 4.40 vs. ALGN: 35.60 )
Ranked among companies with meaningful 3-Year EBITDA Growth Rate only.
ALGN' s 3-Year EBITDA Growth Rate Range Over the Past 10 Years
Min: -35.3  Med: 25.45 Max: 45.2
Current: 35.6
-35.3
45.2
3-Year EPS without NRI Growth Rate 44.00
ALGN's 3-Year EPS without NRI Growth Rate is ranked higher than
88% of the 228 Companies
in the Global Medical Devices industry.

( Industry Median: 1.70 vs. ALGN: 44.00 )
Ranked among companies with meaningful 3-Year EPS without NRI Growth Rate only.
ALGN' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: -76.1  Med: 20.1 Max: 289.3
Current: 44
-76.1
289.3
GuruFocus has detected 3 Warning Signs with Align Technology Inc ALGN.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
» ALGN's 30-Y Financials

Financials (Next Earnings Date: 2018-04-27)


Revenue & Net Income
Cash & Debt
Operating Cash Flow & Free Cash Flow
Operating Cash Flow & Net Income

» Details

Guru Trades

Q1 2017

ALGN Guru Trades in Q1 2017

Jim Simons 1,426,800 sh (+8.38%)
Steve Mandel 2,476,534 sh (unchged)
Mariko Gordon 32,066 sh (unchged)
John Hussman 50,000 sh (unchged)
Steven Cohen Sold Out
Ruane Cunniff 47,593 sh (-1.09%)
Ron Baron 26,040 sh (-2.25%)
Ken Fisher 98,065 sh (-4.09%)
Pioneer Investments 239,434 sh (-16.10%)
Columbia Wanger 1,146,288 sh (-18.15%)
Mario Gabelli 2,000 sh (-20.00%)
» More
Q2 2017

ALGN Guru Trades in Q2 2017

Lee Ainslie 16,140 sh (New)
Caxton Associates 2,900 sh (New)
Ron Baron 106,654 sh (+309.58%)
Jim Simons 1,587,681 sh (+11.28%)
Steve Mandel Sold Out
John Hussman Sold Out
Ken Fisher 96,438 sh (-1.66%)
Pioneer Investments 220,194 sh (-8.04%)
Mario Gabelli 1,800 sh (-10.00%)
Ruane Cunniff 40,144 sh (-15.65%)
Mariko Gordon 23,793 sh (-25.80%)
Columbia Wanger 755,494 sh (-34.09%)
» More
Q3 2017

ALGN Guru Trades in Q3 2017

Andreas Halvorsen 581,967 sh (New)
Jim Simons 2,037,200 sh (+28.31%)
Lee Ainslie 18,610 sh (+15.30%)
Ron Baron 116,493 sh (+9.23%)
Ruane Cunniff Sold Out
Caxton Associates Sold Out
Mariko Gordon 23,667 sh (-0.53%)
Pioneer Investments 218,657 sh (-0.70%)
Ken Fisher 91,526 sh (-5.09%)
Columbia Wanger 637,971 sh (-15.56%)
Mario Gabelli 1,500 sh (-16.67%)
» More
Q4 2017

ALGN Guru Trades in Q4 2017

Caxton Associates 3,560 sh (New)
Joel Greenblatt 5,326 sh (New)
Lee Ainslie 25,650 sh (+37.83%)
Jim Simons 2,614,100 sh (+28.32%)
Ron Baron 116,493 sh (unchged)
Ken Fisher 88,524 sh (-3.28%)
Pioneer Investments 207,444 sh (-5.13%)
Andreas Halvorsen 542,532 sh (-6.78%)
Mariko Gordon 19,099 sh (-19.30%)
Mario Gabelli 1,200 sh (-20.00%)
Columbia Wanger 268,648 sh (-57.89%)
» More
» Details

Insider Trades

Latest Guru Trades with NAS:ALGN

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

GuruDate Trades Impact to Portfolio Price Range * (?) Current Price Change from Average Current Shares
Ken Fisher 2017-12-31 Reduce -3.28%$185.98 - $264.23 $ 259.6815%88,524
Mariko Gordon 2017-12-31 Reduce -19.30%0.05%$185.98 - $264.23 $ 259.6815%19,099
Joel Greenblatt 2017-12-31 New Buy0.02%$185.98 - $264.23 $ 259.6815%5,326
Mario Gabelli 2017-12-31 Reduce -20.00%$185.98 - $264.23 $ 259.6815%1,200
Ron Baron 2017-09-30 Add 9.23%0.01%$149.03 - $188.78 $ 259.6852%116,493
Ken Fisher 2017-09-30 Reduce -5.09%$149.03 - $188.78 $ 259.6852%91,526
Mariko Gordon 2017-09-30 Reduce -0.53%$149.03 - $188.78 $ 259.6852%23,667
Mario Gabelli 2017-09-30 Reduce -16.67%$149.03 - $188.78 $ 259.6852%1,500
Ruane Cunniff 2017-09-30 Sold Out 0.06%$149.03 - $188.78 $ 259.6852%0
Ron Baron 2017-06-30 Add 309.58%0.06%$113.73 - $153.5 $ 259.6892%106,654
Ken Fisher 2017-06-30 Reduce -1.66%$113.73 - $153.5 $ 259.6892%96,438
Ruane Cunniff 2017-06-30 Reduce -15.65%0.01%$113.73 - $153.5 $ 259.6892%40,144
Mariko Gordon 2017-06-30 Reduce -25.80%0.05%$113.73 - $153.5 $ 259.6892%23,793
Mario Gabelli 2017-06-30 Reduce -10.00%$113.73 - $153.5 $ 259.6892%1,800
Steve Mandel 2017-06-30 Sold Out 1.49%$113.73 - $153.5 $ 259.6892%0
Ken Fisher 2017-03-31 Reduce -4.09%$89.98 - $114.71 $ 259.68157%98,065
Ruane Cunniff 2017-03-31 Reduce -1.09%$89.98 - $114.71 $ 259.68157%47,593
Ron Baron 2017-03-31 Reduce -2.25%$89.98 - $114.71 $ 259.68157%26,040
Mario Gabelli 2017-03-31 Reduce -20.00%$89.98 - $114.71 $ 259.68157%2,000
Premium More recent guru trades are included for Premium Members only!!
Premium More recent guru trades are included for USA Subscribe Members only!!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Medical Devices » Medical Devices    NAICS: 339113    SIC: 3842
Compare:NYSE:ZBH, NYSE:EW, LSE:SN., NYSE:TFX, NYSE:VAR, NAS:ABMD, XSWX:SOON, OCSE:WDH, ASX:COH, SZSE:300003, XPAR:DIM, NYSE:BSX, LSE:CTEC, NZSE:FPH, NAS:MASI, NYSE:GMED, OCSE:AMBU B, OCSE:GN, NAS:LIVN, NAS:IART » details
Traded in other countries:AFW.Germany,
Headquarter Location:USA
Align Technology Inc designs, manufactures and markets a system of clear aligner therapy, intra-oral scanners and CAD/CAM digital services used in dentistry, orthodontics, and dental records storage. Its segments are Clear Aligner and Scanners & Services.

Align Technology Inc designs, manufactures and markets a system of clear aligner therapy, intra-oral scanners and CAD/CAM digital services used in dentistry, orthodontics, and dental records storage. Its segments are Clear Aligner and Scanners & Services.

Top Ranked Articles about Align Technology Inc

Consolidated Research: 2018 Summary Expectations for Align Technology, II-VI, EXTRACTION O&G, PPL, ConocoPhillips, and FIRST REPUBLIC BANK — Fundamental Analysis, Key Performance Indications
General Motors Updates Guidance on Tuesday The automaker jumped on strong outlook
U.S. stock markets are set to open high on Tuesday after the Empire State manufacturing fell index to 17.7 in January from 19.6 the previous month. Despite the fall, the index remains in a level which indicates solid growth. Read more...
Report: Developing Opportunities within PPL, ConocoPhillips, First Republic Bank, Align Technology, II-VI, and Extraction O&G — Future Expectations, Projections Moving into 2018
SmileDirectClub Fights Back, Files Lawsuit Against Michigan Dental Association
US Stock Market Opens Higher on Solid Economic Data Amazon soars on earnings beat
Wall Street opened in green on Friday, fueled by solid economic data. In the third quarter, the economy grew at a 3% annual rate despite the impact of natural disasters like Hurricanes Harvey and Irma. The figure is above expectations of a 2.7% growth rate but below the 3.1% growth rate in the past quarter. Read more...
SmileDirectClub Continues to Disrupt the Status Quo, Fights for Consumer Access
Align Technology, Inc. to Join the NASDAQ-100 Index Beginning October 23, 2017
5 Companies Reach 52-Week Highs Align, LyondellBasell, Aflac, Waste Management and Rockwell achieve annual benchmarks
According to GuruFocus' list, these stocks have reached their 52-week highs. Read more...
John Hussman Exits Ebix and Amazon, Sells Mattel Guru's largest sales of the 2nd quarter
John Hussman (Trades, Portfolio) is the president and principal shareholder of Hussman Strategic Advisors, the investment advisory firm that manages the Hussman Funds. During the second quarter the guru sold shares in the following stocks: Read more...
Invisalign® Brand Teams Up With Superstar Athletes Gabrielle Reece, Laird Hamilton, And Their Daughter Reece To Inspire Others To Focus On Achieving Their Personal Goals And Wellbeing

Ratios

vs
industry
vs
history
PE Ratio 91.44
ALGN's PE Ratio is ranked lower than
89% of the 181 Companies
in the Global Medical Devices industry.

( Industry Median: 28.67 vs. ALGN: 91.44 )
Ranked among companies with meaningful PE Ratio only.
ALGN' s PE Ratio Range Over the Past 10 Years
Min: 5.57  Med: 33.83 Max: 222.88
Current: 91.44
5.57
222.88
Forward PE Ratio 59.17
ALGN's Forward PE Ratio is ranked lower than
92% of the 48 Companies
in the Global Medical Devices industry.

( Industry Median: 25.06 vs. ALGN: 59.17 )
Ranked among companies with meaningful Forward PE Ratio only.
N/A
PE Ratio without NRI 91.44
ALGN's PE Ratio without NRI is ranked lower than
89% of the 180 Companies
in the Global Medical Devices industry.

( Industry Median: 28.67 vs. ALGN: 91.44 )
Ranked among companies with meaningful PE Ratio without NRI only.
ALGN' s PE Ratio without NRI Range Over the Past 10 Years
Min: 5.57  Med: 33.83 Max: 222.88
Current: 91.44
5.57
222.88
Price-to-Owner-Earnings 92.61
ALGN's Price-to-Owner-Earnings is ranked lower than
80% of the 103 Companies
in the Global Medical Devices industry.

( Industry Median: 35.70 vs. ALGN: 92.61 )
Ranked among companies with meaningful Price-to-Owner-Earnings only.
ALGN' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 5.35  Med: 34.3 Max: 895
Current: 92.61
5.35
895
PB Ratio 18.10
ALGN's PB Ratio is ranked lower than
93% of the 307 Companies
in the Global Medical Devices industry.

( Industry Median: 2.85 vs. ALGN: 18.10 )
Ranked among companies with meaningful PB Ratio only.
ALGN' s PB Ratio Range Over the Past 10 Years
Min: 1.86  Med: 5.53 Max: 19.26
Current: 18.1
1.86
19.26
PS Ratio 15.75
ALGN's PS Ratio is ranked lower than
84% of the 296 Companies
in the Global Medical Devices industry.

( Industry Median: 3.19 vs. ALGN: 15.75 )
Ranked among companies with meaningful PS Ratio only.
ALGN' s PS Ratio Range Over the Past 10 Years
Min: 1.31  Med: 5.08 Max: 17.22
Current: 15.75
1.31
17.22
Price-to-Free-Cash-Flow 97.73
ALGN's Price-to-Free-Cash-Flow is ranked lower than
92% of the 106 Companies
in the Global Medical Devices industry.

( Industry Median: 31.00 vs. ALGN: 97.73 )
Ranked among companies with meaningful Price-to-Free-Cash-Flow only.
ALGN' s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 11.18  Med: 24.02 Max: 28460
Current: 97.73
11.18
28460
Price-to-Operating-Cash-Flow 59.34
ALGN's Price-to-Operating-Cash-Flow is ranked lower than
87% of the 130 Companies
in the Global Medical Devices industry.

( Industry Median: 20.56 vs. ALGN: 59.34 )
Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.
ALGN' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 8.24  Med: 20.19 Max: 351.69
Current: 59.34
8.24
351.69
EV-to-EBIT 56.96
ALGN's EV-to-EBIT is ranked lower than
83% of the 174 Companies
in the Global Medical Devices industry.

( Industry Median: 24.04 vs. ALGN: 56.96 )
Ranked among companies with meaningful EV-to-EBIT only.
ALGN' s EV-to-EBIT Range Over the Past 10 Years
Min: -378.4  Med: 23.45 Max: 157.9
Current: 56.96
-378.4
157.9
EV-to-EBITDA 52.96
ALGN's EV-to-EBITDA is ranked lower than
88% of the 187 Companies
in the Global Medical Devices industry.

( Industry Median: 18.40 vs. ALGN: 52.96 )
Ranked among companies with meaningful EV-to-EBITDA only.
ALGN' s EV-to-EBITDA Range Over the Past 10 Years
Min: -248.4  Med: 20.2 Max: 243.5
Current: 52.96
-248.4
243.5
EV-to-Revenue 13.67
ALGN's EV-to-Revenue is ranked lower than
80% of the 312 Companies
in the Global Medical Devices industry.

( Industry Median: 3.64 vs. ALGN: 13.67 )
Ranked among companies with meaningful EV-to-Revenue only.
ALGN' s EV-to-Revenue Range Over the Past 10 Years
Min: 0.9  Med: 4.75 Max: 16.8
Current: 13.67
0.9
16.8
PEG Ratio 3.36
ALGN's PEG Ratio is ranked lower than
59% of the 75 Companies
in the Global Medical Devices industry.

( Industry Median: 2.30 vs. ALGN: 3.36 )
Ranked among companies with meaningful PEG Ratio only.
ALGN' s PEG Ratio Range Over the Past 10 Years
Min: 1.22  Med: 1.68 Max: 3.36
Current: 3.36
1.22
3.36
Shiller PE Ratio 189.54
ALGN's Shiller PE Ratio is ranked lower than
91% of the 54 Companies
in the Global Medical Devices industry.

( Industry Median: 47.20 vs. ALGN: 189.54 )
Ranked among companies with meaningful Shiller PE Ratio only.
ALGN' s Shiller PE Ratio Range Over the Past 10 Years
Min: 73.35  Med: 102.04 Max: 680.5
Current: 189.54
73.35
680.5
Current Ratio 2.39
ALGN's Current Ratio is ranked lower than
55% of the 329 Companies
in the Global Medical Devices industry.

( Industry Median: 2.71 vs. ALGN: 2.39 )
Ranked among companies with meaningful Current Ratio only.
ALGN' s Current Ratio Range Over the Past 10 Years
Min: 1.59  Med: 2.95 Max: 6.96
Current: 2.39
1.59
6.96
Quick Ratio 2.31
ALGN's Quick Ratio is ranked higher than
54% of the 329 Companies
in the Global Medical Devices industry.

( Industry Median: 2.03 vs. ALGN: 2.31 )
Ranked among companies with meaningful Quick Ratio only.
ALGN' s Quick Ratio Range Over the Past 10 Years
Min: 1.55  Med: 2.88 Max: 6.82
Current: 2.31
1.55
6.82
Days Inventory 34.01
ALGN's Days Inventory is ranked higher than
91% of the 296 Companies
in the Global Medical Devices industry.

( Industry Median: 141.33 vs. ALGN: 34.01 )
Ranked among companies with meaningful Days Inventory only.
ALGN' s Days Inventory Range Over the Past 10 Years
Min: 9.28  Med: 24.09 Max: 34.01
Current: 34.01
9.28
34.01
Days Sales Outstanding 79.97
ALGN's Days Sales Outstanding is ranked lower than
63% of the 279 Companies
in the Global Medical Devices industry.

( Industry Median: 66.85 vs. ALGN: 79.97 )
Ranked among companies with meaningful Days Sales Outstanding only.
ALGN' s Days Sales Outstanding Range Over the Past 10 Years
Min: 57.57  Med: 63.3 Max: 83.63
Current: 79.97
57.57
83.63
Days Payable 37.66
ALGN's Days Payable is ranked lower than
70% of the 261 Companies
in the Global Medical Devices industry.

( Industry Median: 61.22 vs. ALGN: 37.66 )
Ranked among companies with meaningful Days Payable only.
ALGN' s Days Payable Range Over the Past 10 Years
Min: 25.83  Med: 46.94 Max: 68.75
Current: 37.66
25.83
68.75

Buy Back

vs
industry
vs
history
3-Year Average Share Buyback Ratio 0.40
ALGN's 3-Year Average Share Buyback Ratio is ranked higher than
89% of the 247 Companies
in the Global Medical Devices industry.

( Industry Median: -5.70 vs. ALGN: 0.40 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
ALGN' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -139.2  Med: -3.4 Max: 0.5
Current: 0.4
-139.2
0.5

Valuation & Return

vs
industry
vs
history
Price-to-Net-Cash 127.30
ALGN's Price-to-Net-Cash is ranked lower than
93% of the 101 Companies
in the Global Medical Devices industry.

( Industry Median: 13.00 vs. ALGN: 127.30 )
Ranked among companies with meaningful Price-to-Net-Cash only.
ALGN' s Price-to-Net-Cash Range Over the Past 10 Years
Min: 1.73  Med: 20.84 Max: 417
Current: 127.3
1.73
417
Price-to-Net-Current-Asset-Value 35.58
ALGN's Price-to-Net-Current-Asset-Value is ranked lower than
90% of the 211 Companies
in the Global Medical Devices industry.

( Industry Median: 7.36 vs. ALGN: 35.58 )
Ranked among companies with meaningful Price-to-Net-Current-Asset-Value only.
ALGN' s Price-to-Net-Current-Asset-Value Range Over the Past 10 Years
Min: 1.35  Med: 9.32 Max: 35.58
Current: 35.58
1.35
35.58
Price-to-Tangible-Book 19.62
ALGN's Price-to-Tangible-Book is ranked lower than
89% of the 273 Companies
in the Global Medical Devices industry.

( Industry Median: 4.30 vs. ALGN: 19.62 )
Ranked among companies with meaningful Price-to-Tangible-Book only.
ALGN' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 0.91  Med: 6.29 Max: 19.62
Current: 19.62
0.91
19.62
Price-to-Intrinsic-Value-Projected-FCF 6.13
ALGN's Price-to-Intrinsic-Value-Projected-FCF is ranked lower than
79% of the 122 Companies
in the Global Medical Devices industry.

( Industry Median: 2.37 vs. ALGN: 6.13 )
Ranked among companies with meaningful Price-to-Intrinsic-Value-Projected-FCF only.
ALGN' s Price-to-Intrinsic-Value-Projected-FCF Range Over the Past 10 Years
Min: 1.38  Med: 2.29 Max: 14.76
Current: 6.13
1.38
14.76
Price-to-Median-PS-Value 3.11
ALGN's Price-to-Median-PS-Value is ranked lower than
95% of the 239 Companies
in the Global Medical Devices industry.

( Industry Median: 1.01 vs. ALGN: 3.11 )
Ranked among companies with meaningful Price-to-Median-PS-Value only.
ALGN' s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.35  Med: 0.86 Max: 6.25
Current: 3.11
0.35
6.25
Price-to-Peter-Lynch-Fair-Value 3.15
ALGN's Price-to-Peter-Lynch-Fair-Value is ranked lower than
76% of the 45 Companies
in the Global Medical Devices industry.

( Industry Median: 1.96 vs. ALGN: 3.15 )
Ranked among companies with meaningful Price-to-Peter-Lynch-Fair-Value only.
ALGN' s Price-to-Peter-Lynch-Fair-Value Range Over the Past 10 Years
Min: 0.57  Med: 1.98 Max: 14.72
Current: 3.15
0.57
14.72
Price-to-Graham-Number 8.17
ALGN's Price-to-Graham-Number is ranked lower than
91% of the 136 Companies
in the Global Medical Devices industry.

( Industry Median: 2.11 vs. ALGN: 8.17 )
Ranked among companies with meaningful Price-to-Graham-Number only.
ALGN' s Price-to-Graham-Number Range Over the Past 10 Years
Min: 0.85  Med: 3.31 Max: 17.76
Current: 8.17
0.85
17.76
Earnings Yield (Greenblatt) % 1.76
ALGN's Earnings Yield (Greenblatt) % is ranked higher than
57% of the 332 Companies
in the Global Medical Devices industry.

( Industry Median: 0.86 vs. ALGN: 1.76 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) % only.
ALGN' s Earnings Yield (Greenblatt) % Range Over the Past 10 Years
Min: -6  Med: 3.7 Max: 9.7
Current: 1.76
-6
9.7
Forward Rate of Return (Yacktman) % 39.56
ALGN's Forward Rate of Return (Yacktman) % is ranked higher than
91% of the 125 Companies
in the Global Medical Devices industry.

( Industry Median: 6.87 vs. ALGN: 39.56 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) % only.
ALGN' s Forward Rate of Return (Yacktman) % Range Over the Past 10 Years
Min: -1.1  Med: 2.8 Max: 40
Current: 39.56
-1.1
40

More Statistics

Revenue (TTM) (Mil) $1,473.41
EPS (TTM) $ 2.84
Beta1.69
Short Percentage of Float3.52%
52-Week Range $100.03 - 287.32
Shares Outstanding (Mil)80.18

Analyst Estimate

Dec18 Dec19
Revenue (Mil $) 1,777 2,109
EBIT (Mil $)
EBITDA (Mil $)
EPS ($) 4.58 5.85
EPS without NRI ($) 4.58 5.85
EPS Growth Rate
(Future 3Y To 5Y Estimate)
N/A
Dividends per Share ($)

Piotroski F-Score Details

Piotroski F-Score: 77
Positive ROAY
Positive CFROAY
Higher ROA yoyY
CFROA > ROAY
Lower Leverage yoyY
Higher Current Ratio yoyN
Less Shares Outstanding yoyN
Higher Gross Margin yoyY
Higher Asset Turnover yoyY

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}